Monday, December 27, 2004

Recent drug warnings may spur major overhaul of FDA safety procedures
Boston Globe story reprinted at PsycPORT - "Just as the Enron scandal triggered an overhaul of corporate accounting practices, the nation's prescription drug crisis may prompt a sweeping revamp of the way the Food and Drug Administration ensures drug safety, some say. The momentum for FDA reform is driven by the recent parade of drug problems dominating the nation's front pages, including antidepressants that heighten suicidal thoughts and behaviors among children, and the painkillers naproxen, Bextra, Celebrex, and Vioxx increasing the risk of heart attacks or strokes..."